Benzinga

Benzinga

Benzinga

domingo, agosto 30

Mereo BioPharma Group PLC

MREONASDAQ
Trade with Public
Trade with Public
$0.2525
-0.0195-7.17%
al cierre: Aug 28, 5:00 PM EST
$0.2575
0.0051.98%
After hour: Aug 28, 7:52 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Mereo BioPharma Group Financials

Mereo BioPharma Group (MREO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Mereo BioPharma Group Q2 EPS $(0.01), Inline

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.
Benzinga Newsdesk

PRO
Mereo BioPharma Group Q1 EPS $(0.01), Inline

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.
Benzinga Newsdesk

PRO
Mereo BioPharma Group Q4 EPS $(0.01), Inline

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year.
Benzinga Newsdesk

Silver Tumbles 8%; Society Pass Shares Spike Higher

Avi Kapoor

Dow Falls Over 100 Points; US Pending Home Sales Rise In November

Avi Kapoor

PRO
Mereo BioPharma Group Q3 EPS $(0.01) Beats $(0.03) Estimate

Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved